Established in 2023, Genome Technologies Limited (GTL) is a spin-off biotechnology company of the Centre for Translational Stem Cell Biology with patented advanced genome editing technology.
Specializing in AI-assisted sgRNA design, efficient electroporation and ES cell injection technologies, Genome Technologies Limited (GTL) is determined to reduce the social cost for academic institutions and clinical therapeutic drug/ antibody discovery enterprises by providing highly efficient genome editing services.

As a member of HKSTP Incu-Bio Program, GTL is connected with a wide variety of experts from different areas both locally and all over the world.

GTL has established comprehensive experimental animal research centers in Hong Kong, Shenzhen and Chongqing that includes a small animal breeding center focused on mice and a large animal breeding center focused on pigs.
These facilities are well equipped with a wide variety of apparatus and experts to provide customers with efficient and comprehensive services.

GTL aims to help researchers obtain high-quality model animals quickly, while providing support for scientific research and therapeutic development using out precise and efficient gene editing technology.